Form 4 for RMD ResMed|
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-03 · accession 0001127602-25-007977 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-03-03 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | M - OptEx | $182.90 | +9,113 | 18.8K | +94% | +$1.67M |
| DM | 2025-03-04 | 2025-03-03 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | S - Sale+OE | $235.40 | -9,113 | 14.5K | -39% | -$2.15M |
| DM | 2025-03-04 | 2025-03-03 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | M - OptEx | $0.00 | -9,113 | 5,882 | -61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-03-03 | M | A | 367 | $211.76 | 10,092 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2025-03-03 | M | A | 3,506 | $146.34 | 13,598 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2025-03-03 | M | A | 514 | $146.34 | 14,112 | D | — | — | |
| 4 | Common | ResMed Common Stock | 2025-03-03 | M | A | 4,726 | $211.76 | 18,838 | D | — | — | |
| 5 | Common | ResMed Common Stock | 2025-03-03 | S | D | 367 | $235.25 | 18,471 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. |
| 6 | Common | ResMed Common Stock | 2025-03-03 | S | D | 3,506 | $235.40 | 14,965 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. |
| 7 | Common | ResMed Common Stock | 2025-03-03 | S | D | 4,726 | $235.43 | 9,725 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. |
| 8 | Common | ResMed Common Stock | 2025-03-03 | S | D | 514 | $235.25 | 14,451 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. |
| 9 | Derivative | ResMed Common Stock Options | 2025-03-03 | M | D | 514 | $0.00 | 169 | D | $146.34 · 2019-11-21 to 2026-11-21 | 514 ResMed Common Stock | (F3) Represents date options first become exercisable. Options vest 1/3 per year. |
| 10 | Derivative | ResMed Common Stock Options | 2025-03-03 | M | D | 367 | $0.00 | 105 | D | $211.76 · 2020-11-19 to 2027-11-19 | 367 ResMed Common Stock | (F3) Represents date options first become exercisable. Options vest 1/3 per year. |
| 11 | Derivative | ResMed Common Stock Options | 2025-03-03 | M | D | 3,506 | $0.00 | 3,589 | D | $146.34 · 2019-11-21 to 2026-11-21 | 3,506 ResMed Common Stock | (F3) Represents date options first become exercisable. Options vest 1/3 per year. |
| 12 | Derivative | ResMed Common Stock Options | 2025-03-03 | M | D | 4,726 | $0.00 | 5,882 | D | $211.76 · 2020-11-19 to 2027-11-19 | 4,726 ResMed Common Stock | (F3) Represents date options first become exercisable. Options vest 1/3 per year. |